SOX2 and familial pancreatic carcinoma: Reduced Sox2 levels in glioblastoma tumor-initiating cells can cause proliferation to cease and a loss of tumorigenicity (25), while overexpression of Sox2 in pancreatic cancer is correlated with an invasive and metastatic phenotype (26).